Multi Dwi Abadi is primarily engaged in pharmaceuticals activity. Its headquarters is located in Jawa Timur. The company was founded in 2010. Multi Dwi Abadi was established by a group of visionary entrepreneurs with a mission to enhance healthcare accessibility and quality in Indonesia. The company focuses on the production and distribution of a wide range of pharmaceutical products, including over-the-counter medications, prescription drugs, and health supplements. As a key player in the Indonesian pharmaceutical industry, Multi Dwi Abadi has expanded its operations to include several branches across major cities in Indonesia, ensuring a robust local geographical footprint. The company is committed to maintaining high standards of quality and compliance, adhering to both national and international pharmaceutical regulations. Multi Dwi Abadi's product portfolio includes well-known brands that cater to various therapeutic areas such as cardiovascular health, pain management, and respiratory care. The company is also actively involved in research and development to introduce innovative healthcare solutions to the market. In addition to its domestic operations, Multi Dwi Abadi has established partnerships with international pharmaceutical companies to enhance its product offerings and expand its reach in the Southeast Asian market. The company is a member of several industry associations, which helps it stay abreast of the latest trends and regulatory changes in the pharmaceutical sector. With a vision to become a leading pharmaceutical company in the region, Multi Dwi Abadi is dedicated to improving public health through the provision of safe, effective, and affordable medications. The company's mission is to contribute to the well-being of society by delivering high-quality healthcare products and services.
Headquarters
Ruko Rungkut Makmur blok C No. 56 Jl. Raya Rungkut No. 27
Surabaya; East Java;
Postal Code: 60295
Contact Details: Purchase the PT Multi Dwi Abadi report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service